Argeris N. Karabelas, Director at Vanda Pharmaceuticals Inc. (VNDA), sold 384,130 shares at $26.02 ($10.0M) on 2007-02-23, disclosed to the SEC on 2007-02-27.
Open-market sale of $10.0M VNDA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.02 | 24,661 | $642K | 6.4% |
| 2 | $26.02 | 359,469 | $9.4M | 93.6% |
| Total | $26.02 avg | 384,130 | $10.0M | 100% |
| Filing → |
| RGNX | SELL | 2024-08-05 | $136K | — | Filing → |
| RGNX | SELL | 2024-07-30 | $166K | — | Filing → |
| RGNX | SELL | 2024-07-03 | $113K | — | Filing → |